10X Genomics Reagent Kits for NIDDK

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the Department of Health and Human Services' National Institutes of Health, is procuring a bundled set of 10x Genomics consumables and an instrument upgrade for single-cell and spatial transcriptomics research projects. The procurement includes Single-cell RNA-seq reagents using Chromium Next GEM v3.1 chemistry, Single-cell RNA + TCR-seq kits for immune-repertoire profiling, spatial transcriptomics reagents for Xenium In Situ and Visium HD workflows, and an upgrade from an existing Chromium Controller to a CytAssist instrument. This is a combined synopsis/solicitation for commercial items with brand-name specifications, and quotes must be submitted electronically to jacob.balenson@nih.gov by 5:00 PM EDT on September 21, 2025. The contract will be awarded based on best value evaluation across four criteria: Cost/Price, Past Performance, Delivery Terms, and Technical Capability to meet the requirements outlined in the Statement of Need. The procurement is being conducted under FAR Parts 12 and 13 as a simplified acquisition below the $250,000 threshold, with a performance period of 60 days after receipt of order.

This opportunity is designated as a Total Small Business set-aside under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing), restricting participation to qualified small businesses. Government Scientific Source, Inc. has been identified as the authorized distributor for 10x Genomics products through GSA, though no specific incumbent contractor is mentioned in the solicitation documents. While the exact contract value is not disclosed, the procurement falls within the simplified acquisition threshold range of $10,000 to $250,000 based on the justification documentation. The solicitation specifies delivery of various quantities of reagent kits, consumables, and instrument upgrades, all of which must be delivered within 60 days to the NIH NIDDK facility located in Bethesda, Maryland. The procurement supports critical research into cellular homeostasis and disease mechanisms, enabling high-resolution mapping of cellular states and spatial gene expression across multiple NIDDK research projects.